Term Stim™

US and International Patents Pending

Term Stim™ is a patent-pending, HIPAA-compliant SaaS platform that brings Translational Fertility’s expertise to physicians managing difficult reproductive cases, including poor egg quality and recurrent implantation failure.

Designed for Research and Collaboration

Term Stim™ interface is designed specifically to facilitate case discussion, near real-time chat, and other productivity tools, including a mobile app.

Diagnostic Cycle

For routine IVF, granular cycle data is rarely actionable. For complex cases, however, a detailed physiologic study is essential. Therefore every Term Stim™ engagement begins with a diagnostic cycle – about one month of structured monitoring – to map the patient’s reproductive dynamics, identify potential contributors to poor egg quality, and generate guidance for the subsequent treatment cycle.

For example, you may find that a patient’s follicles begin to luteinize at 16 mm (not 18 mm), with progesterone rising from 0.1 ng/mL to 0.4 ng/mL. This points to the need for a pre-emptive trigger and helps determine whether premature luteinization affects one follicle or the entire cohort.

It also gives an opportunity to test and quantify the patient’s response to medications planned for treatment. For instance, we confirm whether FSH kinetics follow the expected compounding profile; if not, we help you define dose and timing adjustments.

When appropriate, the diagnostic cycle can transition directly into treatment – for example, if an unexpectedly well-synchronized cohort is observed after an LH surge.

Treatment Cycle

The board: A structured case board (timeline + variable panes) that shows the whole case at a glance.
The pieces: Growth tempo, cohort synchrony, historic and current FSH, P4, E2 and LH trends , micro P4 drift, E2–size concordance, prior cycle kinetics, looks backs, medication states, etc.
The rules: Latest reproductive physiology, proprietary and patent pending algorithms, protocol preferences, evidence weighting etc.
Briefs: Step-by-step briefs, based on evidence driven synthesis, that you can review in under a minute.  

For essential data entry you and staff members can use our mobile app with very intuitive interface.  

The Term Stim™ platform enables physicians to deliver previously unattainable level of care to their patients as a premium service. 

Evidence driven synthesis. Case specific briefs. 

Limited Use of AI

In medicine, AI is very successful at searching for and applying a template that worked for a similar patient. But in cases of poor egg quality, this approach is rarely fruitful, since each case is unique. Therefore, in Term Stim™, we use AI only to help track relevant variables and identify subtle trends in a patient’s data that might otherwise be overlooked. However, all validation, interpretation, and recommendations remain entirely human – grounded in research, experience, and expertise.

ASRM 2025